The Relationship between the Presence of Chromosomal Instability and Prognosis of Squamous Cell Carcinoma of the Lung: Fluorescence in situ Hybridization Analysis of Paraffin-embedded Tissue from 47 Korean Patients by Yoo, Jung-Wan et al.
INTRODUCTION
Lung cancer is a leading cause of death in both men and
women in developed countries. To date, a number of genetic
events that promote lung carcinoma tumorigenesis, a mul-
tifactorial process, have been identified (1).
Chromosomal abnormality is one of the hallmarks of neo-
plastic cells, and the persistent chromosomal instability is
reported in human cancers (2). Chromosomal instability (CIN)
or aneusomy occurs at the chromosomal level, resulting in
losses and gains of whole chromosomes (3). CIN can be detect-
ed using fluorescence in situ hybridization (FISH) to measure
fluorescence signals from targeted chromosomes in the inter-
phase nuclei of surgical specimens of non-small cell lung can-
cer (NSCLC) (4, 5). CIN in NSCLC may be an independent
factor for predicting poor prognosis (4). Recent study report-
ed CIN-positive, defined as at least the existence of three chro-
mosome aneusomy in primary adenocarcinoma (AC) of the
lung with FISH, was associated with poor prognosis, and thus
advocated as an independent prognostic factor in Korean pa-
tients (6). However, in squamous cell carcinoma (SCC) of the
lung, the second most frequent histologic subtype, the rela-
tionship between CIN-positive and prognosis remains to be
established. In the present study, we investigated the num-
ber of chromosomal aneusomy to define CIN-positive, and
analyzed the relationship between CIN-positive and survival
using FISH in Korean patients with SCC of the lung.
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The Relationship between the Presence of Chromosomal Instability and
Prognosis of Squamous Cell Carcinoma of the Lung: Fluorescence 
in situ Hybridization Analysis of Paraffin-embedded Tissue from 47
Korean Patients
To evaluate the prognostic importance of chromosomal instability (CIN) in squa-
mous cell carcinoma (SCC) of the lung, the relationship between CIN detected by
fluorescence in situ hybridization (FISH) and survival in SCC patients was exam-
ined. Forty-seven surgical specimens of lung SCC were analyzed. To identify tumors
with CIN, p16 and multi-target DNA FISH assays for c-myc, chromosome 6, EGFR,
and chromosome 5 (LAVysion, Vysis) were performed on nuclei extracted from
paraffin-embedded tumor tissues. Survival rates were compared in terms of age, T
factor, N factor, CIN, and smoking status. A sample was defined as CIN-positive if
at least four of the five chromosomes were positive. Among the 47 specimens, 9
(19%) were CIN-positive. The overall survival rate was 66%. Overall survival rates
were estimated as 33.3% for CIN-positive patients and 76.7% for CIN-negative
patients (Hazard ratio 3.47; 95% Confidence interval, 1.25-9.67; P=0.017). In mul-
tivariate analysis, the presence of CIN was a predictive factor for survival. CIN-posi-
tive based on FISH can be prognostic factor of lung SCC. 
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Participants
We reviewed the clinical characteristics and pathological
specimens of 47 patients with squamous cell carcinoma of
the lung subjected to resection at the Asan Medical Center,
Seoul, from January 2002 to May 2003. This study proto-
col was approved by the Asan Medical Center Institutional
Ethics Review Board (2008-0026). Patients included 46 men
and 1 woman with a median of 59 yr. Lobectomy was per-
formed in 40 (85.1%) patients, and pneumonectomy in the
remaining 7 (14.9%) cases. All patients were subjected to
mediastinal lymph node dissection. No presurgical chemo-
therapy or radiotherapy was administered. Diagnosis of lung
SCC was confirmed by histological examination of the sur-
gical specimens. Tumor-node-metastasis staging of cancers
was performed using the latest criteria (7). The pathological
stage was classified as I in 22 patients, II in 17 patients, and
III in 8 patients. Patients were regularly monitored in the
outpatient department for 72 months after tumor resection.
The demographic and clinical characteristics of patients are
summarized in Table 1.
Extraction of nuclei from paraffin-embedded tissues
We performed FISH on cell nuclei isolated from both tumor
and control samples, as described previously (8). To set the
normal reference range of the FISH probe, mononuclear cells
of peripheral blood from 20 healthy individuals were used
as the control. The mean+3 S.D. (standard deviation) value
of the normal range was set as the reference. Paraffin-embed-
ded tissue samples and glass pellets 1-mm-diameter were
placed in small nylon gauze bags. The material was deparaf-
finized with xylene for 1.5-3 hr, followed by incubation with
decreasing concentrations of ethanol (100%, 90%, 70%, and
35% for 1 hr, respectively). Deparaffinized tissue specimens
were transferred into distilled water, and incubated with 0.1%
protease (Sigma P8038, St. Louis, MO, USA) in 0.1N Tris-
HCl at 37℃ for 3-10 min. Following termination of diges-
tion by incubation on ice and centrifugation (8 min, 500 rpm),
the supernatant was removed, and cell pellet resuspended in
200 mL of Canoy’s fixative. The cell suspension (10 mL) was
dropped on a positively charged slide and air-dried. Samples
were immediately processed for FISH analysis.
Fluorescent in situ hybridization study
FISH was performed according to the manufacturer’s in-
structions with minor modifications, as described in a previ-
ous report (9). The commercially available multi-target FISH
assay (LAVysion; Vysis; Downers Grove, IL, USA) includes
directly labeled DNA FISH probes for EGFR (7p12,Spec-
trumRed), MYC (8q24,SpectrumGold), chromosome 5 (5p-
15.2,SpectrumGreen), and chromosome 6 (centrometric at
6p11.1-q11,SpectrumAqua). FISH analysis of p16 was con-
ducted using the LSI
� p16 (9p21) SpectrumOrange/CEP
�9
SpectrumGreenTM Probe (Vysis; IL, USA). After staining,
4′ ,6-diamidino-2-phenylindole (DAPI II) (Abott/Vysis) was
applied to the target areas, and the slides analyzed under a
fluorescence microscope using single bandpass filter sets. FISH
signals were measured at a magnification of ×630 after auto-
matic relocation of equivocal cells with the appropriate soft-
ware in the DAPI II single bandpass filter set on the micro-
scope. Nuclear signals were only measured in cells with clear-
ly defined nuclear borders and visible signals. In total, 200
nuclei were counted, and the level of each centromeric sig-
nal recorded. EGFR, MYC, chromosome 5, and chromosome
6 (Fig. 1) were analyzed for increased copy number, and the
p16 gene examined for deletion. Cells displaying gain (>2)
or loss (<2) in copy number were determined when they con-
stituted 10% of the total cell population. This cutoff value
was based on earlier studies reporting that the mean+3 S.D.
value of gain or loss of each chromosome in lymphocytes and
normal colorectal epithelium was less than 10% (10).
Statistical analysis
The chi-square test was used to compare categorical vari-
ables, and the Mann-Whitney U-test for continuous non-
parametric variables. The Student’s t-test was applied to com-
pare continuous parametrical variables. Survival rates were
calculated with the Kaplan-Meier method. The significance
of survival differences between subgroups was examined by
univariate analysis using the log-rank method. Survival was
defined as the time from surgery to death or last follow-up.
We assessed the discriminatory ability of CIN number to
predict survival as previous study. A sample was considered
CIN-positive when at least four chromosomal aneusomies
out of the five chromosomes, well known for chromosomal
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Fig. 1. Image of fluorescent in situ hybridization (FISH) performed
on extracted nuclei of lung cancer tissue. (A) LaVysion FISH: cell
showing increase copy number of 7p12, chromosome 5 and 8q24
region. A Cell shows five red signals (7p12 region), three Gold
signals (8q 24 region), four green signals (5p15.2) and two aqua
signals (chromosome 6). (B) p16 FISH: cell with deletion p 16 gene.
A cell shows homozygous deletion of p16 gene (no orange signal)
on normal number of chromosome 9 (two green signal).
A Binstability in lung cancer, were increased copy number or
deleted as described above (6). Patients with predicted mor-
tality were distinguished with 66.7% sensitivity and 73.7%
specificity with this cutoff point. We analyzed CIN status,
age, tumor stage, nodal stage and smoking history using Cox
proportional hazards models to determine predictable factor
for survival. 
A univariate factor with Pvalue of less than 0.20 was select-
ed for multivariate analysis. Factors independently associat-
ed with event were identified. P<0.05 was considered sig-
nificant. Statistical analyses were performed using the SPSS
system for Windows (Version 14.0). 
RESULTS
The median age of both CIN-positive group and CIN-neg-
ative group was 59 yr. The level of lymph node involvement,
tumor stage, and smoking history did not differ significant-
ly between the groups (Table 1). The frequencies of chromo-
somal aneusomy in SCC specimens are summarized in Table
2. Nine cases met our criteria for CIN positive. As of Novem-
ber 2008, 16 patients had died. The mean survival duration
was 52±8 months (95% Confidence interval (CI), 37-67)
for CIN-positive group and 71±3 months (95% CI, 65-78).
The overall survival rate was 66%. Overall survival rates were
estimated as 33.3% for CIN-positive patients and 76.7%
for CIN-negative patients (Hazard ratio (HR) 3.47; 95% CI,
1.25-9.67; P=0.017). Multivariate analysis using Cox pro-
portional hazards models was used to compare survival bet-
ween CIN-positive and CIN-negative patients. In relation
to CIN-negative patients and after adjusting for sex, patho-
logic nodal staging, tumor staging, age, and smoking histo-
ry, the presence of CIN was associated with survival (HR,
3.47; 95% CI, 1.25-9.67; P=0.017) (Table 3). The Kaplan-
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*Data are presented as median (range), number (%); 
� Mann-Whitney
U-test; 
� Fisher’s exact test.
Parameters
All
(n=47)
CIN (+) 
(n=9)
CIN (-)
(n=38)
P
value
Age (yr) 59 (42-70) 59 (42-60) 59 (55-70) 0.604
�
Sex, n (%)
Male 46 (97.9) 9 (100) 37 (97.4) 1
Female 1 (2.1) 0 1 (2.6)
T stage, n (%)
T1 8 (17) 1 (11.1) 7 (18.4) 0.608
�
T2 34 (72.3) 8 (88.9) 24 (68.4)
T3 3 (6.4) 0 3 (7.9)
T4 2 (4.3) 0 2 (5.3)
N stage, n (%)
N0 25 (53.2) 5 (55.6) 20 (52.6) 0.982
�
N1 16 (38) 3 (33.3) 13 (34.2)
N2 6 (8.6) 1 (11.1) 5 (13.2)
TNM stage, n (%)
I 22 (46.8) 5 (55.5) 17 (44.7) 0.946
�
II 17 (36.2) 3 (33.3) 14 (36.9)
III 8 (10.6) 1 (11.1) 7 (18.5)
Smoking, n (%)
None 2 (4.3) 0 2 (5.3) 0.394
�
Former 13 (27.7) 4 (44.4) 9 (23.7) 
Current 32 (68.1) 5 (55.6) 27 (71.1)
Pack year  40 (0-100) 38 (15-60) 40 (0-100) 0.401
�
Operation, n (%)
Lobectomy 40 (85.1) 9 (100) 31 (81.6) 0.318
�
Pneumonectomy 7 (14.9) 0 7 (18.4)
Table 1. Baseline characteristics of study participants*
*Data are presented as mean±standard deviation, number (%), medi-
an (range).
Type of abnormality Number (%)
C-MYC Increase copy number (>10%) 12 (25.5)
Chromosome-5 Increase copy number (>10%) 15 (31.9)
EGFR Increase copy number (>10%) 18 (38.3)
Chromosome-6 Increase copy number (>10%) 8 (17)
p16  Deletion (>10%) 23 (48.9)
Table 2. Frequencies of signals per cell for each DNA probe
included in the FISH assay in squamous cell carcinoma of the
lung*
Univariate analysis
Hazard ratio (95% CI)
Factors P value
Multivariate analysis
Hazard ratio (95% CI)
P value
Age 0.90  (0.82-0.99) 0.041
Sex 3.66  (0.47-28.34) 0.215
T stage 0.58 (0.19-1.81) 0.352
N stage 1.23 (0.74-2.03) 0.417
smoking 2.39 (0.31-18.39) 0.401
C-MYC 2.86 (1.06-7.72) 0.038
Chromosome-5 1.95 (0.72-5.26) 0.188
EGFR 1.85 (0.69-4.95) 0.220
Chromosome-6 2.69 (0.93-7.83) 0.069
p16 1.70 (0.61-4.75) 0.312
CIN 3.47 (1.25-9.67) 0.017 3.47 (1.25-9.67) 0.017
Table 3. Results of univariate and multivariate analysis of prognostic factors for survivalMeier survival curves constructed according to CIN status
after resection of lung SCC are shown in Fig. 2 (P=0.013). 
DISCUSSION
NSCLC accounts for approximately 80% of lung cancers,
and the AC and SCC histologic subtypes represent more than
85% of NSCLC cases (11). Chromosomal instability occurs
at the chromosomal level leading to loss or gain of whole
chromosomes (3) and, chromosomal aneusomy has been rec-
ognized as a marker for lung cancer (12).
FISH is a convenient way to count numbers of specific
chromosomes in interphase nuclei (13). FISH is utilized to
diagnose malignancy and to detect cytogenetic abnormali-
ties (14-16). FISH has been also used to diagnose lung can-
cer in clinical specimens in conjunction with conventional
morphologic analysis (17, 18). In addition, recent study show-
ed chromosomal aneusomy, based on FISH in bronchial high-
grade lesions, was associated with invasive lung cancer (19).
Nakamura and colleagues suggested that the existence of
chromosomal instability was associated with poor survival
in patients with non-small cell lung cancer, based on FISH
analysis of surgical specimens (4). Recently Choi and his col-
leagues effectively detected CIN in primary adenocarcinoma of
the lung using FISH, and showed that CIN-positive, defined
as the number of chromosome aneusomy, was associated with
poor prognosis in adenocarcinoma patients (6). They report-
ed that the 5-yr overall survival rate was estimated as 68.7%
for CIN-positive patients and 93.5% for CIN-negative pati-
ents (HR, 2.34; 95% CI, 1.04-5.26; P=0.04). CIN-positive
status was significantly associated with decreased overall sur-
vival using multivariate Cox proportional hazards models.
It has been not known whether CIN or chromosomal aneu-
somy detected by FISH is associated with poor prognosis in
patients with squamous cell carcinoma of the lung. We eval-
uated distribution of chromosomal instability using FISH
in SCC and assessed the discriminatory ability of CIN num-
ber to predict survival and tried to determine significant asso-
ciation between CIN status and survival. A sample was con-
sidered CIN-positive when at least four of chromosomal aneu-
somy out of the five chromosomes different from that of ade-
nocarcinoma of the lung (6). The overall survival was poor
prognosis in CIN-positive patients compared to CIN-nega-
tive subjects (P=0.013). The multivariate analysis using Cox
model showed correlation between CIN-positive and poor
prognosis in our results. Our study showed CIN status could
be an independent poor prognostic factor in squamous cell
carcinoma of the lung. By revealing CIN status of surgical
specimen after operation of lung cancer, more treatment modal-
ity such as adjuvant chemotherapy or radiotherapy can be
applied to patients to gain survival benefit. 
Our study has some limitations. The patient number was
small and the prognostic effect of CIN in lung SCC needs to
be confirmed in a population with larger sample size or in an
independent cohort. We did not analyze other genetic muta-
tions. Theoretically, carcinogenesis is initiated with genetic
alterations including mutation and changes of copy number.
In that manner, we infer that CIN status is related to other
genetic alterations in lung cancer, although we did not per-
form the mutation study. Due to our facility limitation, we
cannot add chromosomal instability more specific to lung
SCC such as amplification of 3q and 18p or deletion at 2q35,
3p14.1-3p14.3 and so forth (20, 21). To our knowledge, this
is the first report of an association between at four number
of chromosomal instability detected using FISH and survival
of patients with squamous cell carcinoma of the lung. 
In summary, chromosomal instability can be detected effi-
ciently using FISH. CIN positivity was independent poor
prognostic factor in SCC of the lungs. 
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